Enlitic's AI software approved for commercialization in U.S., EU

2019 10 21 17 41 6509 Artificial Intelligence Ai Suit 400

Artificial intelligence (AI) software developer Enlitic said that its Curie platform and the AI application within Curie, Curie|Endex, recently received approval for commercialization in the U.S. and European Union (EU).

Enlitic developer Curie as a platform for hosting multiple AI applications in a manner that enables their use by radiologists without disrupting workflow. Curie|Endex is designed to transform medical imaging data into a standardized nomenclature while enabling relevant clinical content to be connected across disparate IT systems in a hospital.

The company said the products demonstrate compliance to requirements by the U.S. Food and Drug Administration (FDA) and the EU Medical Device Regulations.

Page 1 of 367
Next Page